| Literature DB >> 25672426 |
Camilo Partezani Helito1, Bruno Bonganha Zanon1, Helder de Souza Miyahara1, Jose Ricardo Pecora1, Ana Lucia Munhoz Lima1, Priscila Rosalba de Oliveira1, Jose Ricardo Negreiros de Vicente1, Marco Kawamura Demange1, Gilberto Luis Camanho1.
Abstract
OBJECTIVE: To establish the risk factors for joint infection by oxacillin-resistant Staphylococcus aureus (MRSA) using clinical and epidemiological data.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25672426 PMCID: PMC4311124 DOI: 10.6061/clinics/2015(01)06
Source DB: PubMed Journal: Clinics (Sao Paulo) ISSN: 1807-5932 Impact factor: 2.365
Clinical and epidemiological summary of study results and statistical analysis.
| MRSA group | MSSA group | ||
| 0.708 | |||
| Male | 8 (61.5%) | 16 (72.7%) | |
| Female | 5 (38.5%) | 6 (27.3%) | |
| 40.5 | 39.2 | 0.871 | |
| Leukocytosis | 5 (38.5%) | 15 (68.1%) | |
| Leukocyte count (average) | 10853 | 12915 | 0.325 |
| CRP increase (number of patients) | 12 (92.3%) | 22 (95.6%) | |
| CRP value (average) | 150 | 166 | 0.749 |
| ESR increase (number of patients) | 12 (92.3%) | 22 (95.6%) | |
| ESR value (average) | 69 | 58 | 0.394 |
| Fever | 5 (38.5%) | 9 (40.9%) | 0.886 |
| Pain | 10 (76.9%) | 15 (68.1%) | 0.709 |
| Joint effusion | 10 (76.9%) | 17 (77.2%) | >0.999 |
| Time to diagnosis (days) | 11.4 | 16.6 | 0.585 |
| Gram staining | 7 (53.8%) | 14 (63.6%) | 0.568 |
| 0.586 | |||
| Hematogenic | 12 (92.3%) | 20 (91.0%) | |
| Direct inoculation | 0 | 1 (4.5%) | |
| Contiguity | 1 (7.7%) | 1 (4.5%) | |
| Community | 2 (15.3%) | 16 (72.7%) | |
| Health Services | 11 (84.7%) | 6 (27.3%) | |
| 5 (38.5%) | 8 (36.3%) | >0.999 | |
| 10 (76.9%) | 10 (45.4%) | 0.282 | |
| 1.6 | 0.8 | 0.09 | |
| 5 (38.5%) | 5 (22.7%) | 0.444 | |
| 4 (30.7%) | 1 (4.5%) | ||
| 5 (38.5%) | 2 (9.0%) | ||
| Number of procedures per patients (average) | 2.3 | 1.6 | 0.154 |
| Hospitalization days per patient (average) | 32.8 | 21.5 | 0.109 |
| Systemic complications | 3 (23.0%) | 2 (9.0%) | 0.337 |
| Articular complications | 3 (23.0%) | 4 (18.1%) | >0.999 |
Statistical analysis.
| Variable | |
| Joint | 0.259 |
| Sex | 0.708 |
| Inoculation type | 0.586 |
| Fever | 0.886 |
| Pain | 0.709 |
| Swelling | >0.999 |
| Grams staining | 0.568 |
| Comorbidities | 0.282 |
| Number of comorbidities | 0.09 |
| Immunosuppression | 0.444 |
| Prior joint disease | >0.999 |
| Previous surgery of the affected joint | 0.052 |
| Previous surgery of the affected limb | 0.075 |
| Systemic complications | 0.337 |
| Articular complications | >0.999 |
| Leukocyte count | 0.325 |
| Leukocytosis | 0.086 |
| CRP value | 0.749 |
| ESR value | 0.394 |
| Number of drainages | 0.154 |
| Time from drainage to onset of symptoms | 0.585 |
| Hospitalization time | 0.109 |